scholarly article | Q13442814 |
P2093 | author name string | Rennick D | |
Araujo FG | |||
Slifer T | |||
Hunter CA | |||
Grünig G | |||
Ellis-Neyes LA | |||
Fort M | |||
Kanaly S | |||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Trypanosoma cruzi | Q150162 |
P304 | page(s) | 3311-3316 | |
P577 | publication date | 1997-04-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi | |
P478 | volume | 158 |
Q34001680 | A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice |
Q36771337 | A novel murine model of rhinoscleroma identifies Mikulicz cells, the disease signature, as IL-10 dependent derivatives of inflammatory monocytes. |
Q33760119 | A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease |
Q39829243 | Administration of a nondepleting anti-CD25 monoclonal antibody reduces disease severity in mice infected with Trypanosoma cruzi |
Q79370839 | An unusual pro-inflammatory role of interleukin-10 induced by arabinosylated lipoarabinomannan in murine peritoneal macrophages |
Q37599570 | Anti-myeloperoxidase antibodies attenuate the monocyte response to LPS and shape macrophage development. |
Q59800419 | Arginase-1 Is Responsible for IL-13-Mediated Susceptibility to Trypanosoma cruzi Infection |
Q90701028 | Biology and therapeutic potential of interleukin-10 |
Q35810790 | Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives |
Q34004385 | Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice |
Q34009446 | Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans |
Q36555745 | CD46 Activation Regulates miR-150-Mediated Control of GLUT1 Expression and Cytokine Secretion in Human CD4+ T Cells |
Q37864688 | CD46 in innate and adaptive immunity: an update. |
Q55364024 | CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease. |
Q37310959 | Chagas' disease: an update on immune mechanisms and therapeutic strategies |
Q41544597 | Chronic Chagas' Disease: Targeting the Interleukin-2 Axis and Regulatory T Cells in a Condition for Which There Is No Treatment |
Q33570304 | Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells |
Q26779956 | Complexity and Controversies over the Cytokine Profiles of T Helper Cell Subpopulations in Tuberculosis |
Q35961252 | Consequences of immunopathology for pathogen virulence evolution and public health: malaria as a case study |
Q36229731 | Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. |
Q35539329 | Cowpox virus induces interleukin-10 both in vitro and in vivo |
Q33558006 | Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. |
Q41552272 | Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease |
Q35029066 | Differential inhibitory mechanism of cyclic AMP on TNF-alpha and IL-12 synthesis by macrophages exposed to microbial stimuli |
Q58846223 | Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities |
Q40280437 | Differential use of TLR2 and TLR9 in the regulation of immune responses during the infection with Trypanosoma cruzi |
Q60047543 | Disease Tolerance and Pathogen Resistance Genes May Underlie Persistence and Differential Progression to Chagas Disease Cardiomyopathy |
Q45351747 | Dual role of interleukin-10 in the regulation of respiratory syncitial virus (RSV)-induced lung inflammation |
Q34115997 | During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein |
Q37271763 | During acute experimental infection with the reticulotropic Trypanosoma cruzi strain Tulahuen IL-22 is induced IL-23-dependently but is dispensable for protection |
Q34120889 | Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. |
Q42369872 | Ebi3 Prevents Trypanosoma cruzi-Induced Myocarditis by Dampening IFN-γ-Driven Inflammation |
Q34152059 | Effects of cholinergic stimulation with pyridostigmine bromide on chronic chagasic cardiomyopathic mice. |
Q34003863 | Effects of interleukin-4 deprivation and treatment on resistance to Trypanosoma cruzi |
Q35689168 | Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice |
Q34180786 | Enhanced interleukin-12 and CD40 ligand activities but reduced Staphylococcus aureus Cowan 1-induced responses suggest a generalized and progressively impaired type 1 cytokine pattern for human schistosomiasis. |
Q38927945 | Epstein-Barr virus-induced gene 3 suppresses T helper type 1, type 17 and type 2 immune responses after Trypanosoma cruzi infection and inhibits parasite replication by interfering with alternative macrophage activation |
Q64987410 | Evaluation of pathogen P21 protein as a potential modulator of the protective immunity induced by Trypanosoma cruzi attenuated parasites. |
Q26744672 | Evasion and Immuno-Endocrine Regulation in Parasite Infection: Two Sides of the Same Coin in Chagas Disease? |
Q33767989 | Exacerbated skeletal muscle inflammation and calcification in the acute phase of infection by Mexican Trypanosoma cruzi DTUI strain |
Q34714344 | Experimental Pseudomonas aeruginosa keratitis in interleukin-10 gene knockout mice. |
Q36667633 | Experimental manipulation of immune-mediated disease and its fitness costs for rodent malaria parasites |
Q34003784 | Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia |
Q33721737 | Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling |
Q26778206 | IFN-γ Priming Effects on the Maintenance of Effector Memory CD4(+) T Cells and on Phagocyte Function: Evidences from Infectious Diseases |
Q40342616 | IL-10 Plays Opposing Roles during Staphylococcus aureus Systemic and Localized Infections. |
Q33902365 | IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis |
Q37297787 | IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge |
Q37476110 | IL-10 helps control pathogen load during high-level bacteremia. |
Q35048439 | IL-10 inhibits the NF-κB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes |
Q37439030 | IL-10 is pathogenic during the development of coxsackievirus B4-induced chronic pancreatitis |
Q35659197 | IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection |
Q33927028 | IL-10 production by CD4+ effector T cells: a mechanism for self-regulation |
Q41017961 | IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection |
Q35951526 | IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage |
Q35597423 | IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesis |
Q34266045 | IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils |
Q61815267 | IL-27 Promotes Human Placenta-Derived Mesenchymal Stromal Cell Ability To Induce the Generation of CD4IL-10IFN-γ T Cells via the JAK/STAT Pathway in the Treatment of Experimental Graft-versus-Host Disease |
Q35722876 | IL-27 Signaling Is Crucial for Survival of Mice Infected with African Trypanosomes via Preventing Lethal Effects of CD4+ T Cells and IFN-γ. |
Q35737807 | IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection |
Q37424237 | Ikaros is a regulator of Il10 expression in CD4+ T cells |
Q26799180 | Immune Evasion Strategies of Trypanosoma cruzi |
Q38599837 | Immunity and immune modulation in Trypanosoma cruzi infection |
Q42733135 | Immunopathological aspects of experimental Trypanosoma cruzi reinfections. |
Q35037044 | In pulmonary paracoccidioidomycosis IL-10 deficiency leads to increased immunity and regressive infection without enhancing tissue pathology |
Q39510966 | Increased antimycobacterial immunity in interleukin-10-deficient mice |
Q47261209 | Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus |
Q34186413 | Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice |
Q39555510 | Inflammatory responses and intestinal injury development during acute Trypanosoma cruzi infection are associated with the parasite load |
Q34000030 | Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease |
Q45749622 | Interference of natural mouse hepatitis virus infection with cytokine production and susceptibility to Trypanosoma cruzi |
Q35139231 | Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens |
Q41916760 | Interleukin-10 production by effector T cells: Th1 cells show self control |
Q24653771 | Interleukin-10: new perspectives on an old cytokine |
Q34935751 | Interleukin-12 p40- and Fas Ligand-Dependent Apoptotic Pathways Involving STAT-1 Phosphorylation Are Triggered during Infection with a Virulent Strain ofToxoplasma gondii |
Q26830400 | Interleukin-27: balancing protective and pathological immunity |
Q34999280 | Lack of endogenous IL-10 enhances production of proinflammatory cytokines and leads to Brucella abortus clearance in mice |
Q35754496 | Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice |
Q59136942 | Limited Foxp3 Regulatory T Cells Response During Acute Infection Is Required to Allow the Emergence of Robust Parasite-Specific CD8 T Cell Immunity |
Q34681102 | Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection. |
Q40383030 | Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients |
Q33822234 | Mycobacterium tuberculosis cell wall released fragments by the action of the human lung mucosa modulate macrophages to control infection in an IL-10-dependent manner |
Q34163899 | NADPH phagocyte oxidase knockout mice control Trypanosoma cruzi proliferation, but develop circulatory collapse and succumb to infection. |
Q33946628 | NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells |
Q37067780 | Negative regulation of Th17 responses |
Q35801788 | Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies |
Q35750253 | Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection |
Q37007516 | Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: role in renoprotection in obese rats |
Q36370595 | Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response |
Q34108177 | Regulation of CD8+ T cell responses to infection with parasitic protozoa |
Q21131215 | Regulation of adaptive immunity; the role of interleukin-10 |
Q36974418 | Relapsing fever borreliosis in interleukin-10-deficient mice |
Q24523182 | Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice |
Q90169712 | Resolvin D1 Administration is Beneficial in Trypanosoma cruzi Infection |
Q36120145 | Role of Interleukin-10 on Nasal Polypogenesis in Patients with Chronic Rhinosinusitis with Nasal Polyps |
Q37028880 | Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria. |
Q34262223 | Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease |
Q34281893 | Soluble ST2 in the fetal inflammatory response syndrome: in vivo evidence of activation of the anti-inflammatory limb of the immune response |
Q34793513 | T Cell Activation and Proinflammatory Cytokine Production in Clinically Cured Tuberculosis Are Time-Dependent and Accompanied by Upregulation of IL-10. |
Q91996563 | T-Cell Immunophenotyping and Cytokine Production Analysis in Patients with Chagas Disease 4 Years after Benznidazole Treatment |
Q90170495 | TIGIT limits immune pathology during viral infections |
Q34334393 | The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance |
Q38010707 | The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling |
Q58705710 | The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease |
Q58417804 | The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: A role for interleukin-10 |
Q39512519 | The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi |
Q36710772 | Trypanosoma cruzi induces regulatory dendritic cells in vitro |
Q35439736 | Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells |
Q33597343 | Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice |
Q47162312 | Unconventional Pro-inflammatory CD4+ T Cell Response in B Cell-Deficient Mice Infected with Trypanosoma cruzi. |
Q60932659 | Upregulation of Cardiac IL-10 and Downregulation of IFN- in Balb/c IL-4 in Acute Chagasic Myocarditis due to Colombian Strain of Trypanosoma cruzi |